THX Pharma Société Anonyme (EPA:ALTHX)
3.515
+0.065 (1.88%)
May 14, 2026, 5:19 PM CET
EPA:ALTHX Revenue
In the year 2025, THX Pharma Société Anonyme had annual revenue of 813.00K EUR, down -64.39%. THX Pharma Société Anonyme had revenue of 6.96K in the half year ending December 31, 2025, a decrease of -86.62%.
Revenue
813.00K
Revenue Growth
-64.39%
P/S Ratio
58.55
Revenue / Employee
81.30K
Employees
10
Market Cap
47.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 813.00K | -1.47M | -64.39% |
| Dec 31, 2024 | 2.28M | 1.99M | 670.55% |
| Dec 31, 2023 | 296.33K | -118.57K | -28.58% |
| Dec 31, 2022 | 414.90K | 414.30K | 68,819.93% |
| Dec 31, 2021 | 602.00 | -294.01K | -99.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 20.96M |
| Nicox | 18.95M |
| Fermentalg | 13.38M |
| Innate Pharma | 9.01M |
| MaaT Pharma | 4.52M |
| ABIONYX Pharma | 4.10M |
| Adocia | 3.85M |
| Valerio Therapeutics Société anonyme | 2.57M |